Results 221 to 229 of about 68,999 (229)

Targeting the trunk of multi-root common epilepsy with gene therapy. [PDF]

Mol Ther Methods Clin Dev
Sheibani M, Minassian BA.
europepmc   +1 more source

Methylation Profiles Differ According to Clinical Characteristics in Well-Differentiated Neuroendocrine Tumors of the Lung. [PDF]

Endocr Pathol
Melhorn P, Tomasich E, Blessing A, Brcic L, Kogler A, Draschl A, Mazal P, Berghoff AS, Raderer M, Preusser M, Heller G, Kiesewetter B.   +11 more
europepmc   +1 more source

Treatments and Outcomes in Neuroendocrine Patients Treated with Long-Acting Somatostatin Analogues: An Italian Real-World Propensity Score-Matched Cohort Study. [PDF]

Biomedicines
Ranallo N, Roncadori A, Gentili N, Balzi W, Altini M, Ghini V, Maltoni R, Andalò A, Cavallucci M, Sansovini M, Fausti V, Montella MT, Massa I, Danesi V.   +13 more
europepmc   +1 more source

A phase II study of ramucirumab and somatostatin analog therapy in patients with advanced neuroendocrine tumors. [PDF]

Oncologist
Perez K, Kulke MH, Zheng H, Allen J, Clark J, Enzinger AC, Enzinger PC, Johnson BE, McCleary NJ, Parikh A, Patel A, Rubinson D, Yurgelun MB, Ramsey K, Johnson E, Graham C, Chan JA.   +16 more
europepmc   +1 more source

Refractory hypercalcemia caused by parathyroid-hormone-related peptide secretion from a metastatic pancreatic neuroendocrine tumor: a case report. [PDF]

J Med Case Rep
Haimi M, Yang JW, Kremer R.
europepmc   +1 more source

Pancreatic endocrine and exocrine signaling and crosstalk in physiological and pathological status. [PDF]

Signal Transduct Target Ther
Hu C, Chen Y, Yin X, Xu R, Yin C, Wang C, Zhao Y.   +6 more
europepmc   +1 more source